Kintara Therapeutics Issues Correction Regarding CVR Issuance Timing For Proposed Merger With TuHURA Biosciences, Now Set For Immediately Before Reverse Stock Split; Merger Expected To Close On October 18, 2024
Author: Benzinga Newsdesk | October 15, 2024 04:18pm